Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.44B |
| 2 |
Bausch Health
BHC
|
+$267M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$179M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$176M |
| 5 |
T-Mobile US
TMUS
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Retail ETF
XRT
|
+$629M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$501M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$473M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$242M |
| 5 |
eBay
EBAY
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.67% |
| 2 | Technology | 4.59% |
| 3 | Energy | 3.93% |
| 4 | Financials | 3.85% |
| 5 | Communication Services | 3.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
PUT
Ryder
R
$10.1B
| $239K | ﹤0.01% |
2,600
-2,400
| -48% | -$214K |
|
4377
CALL
Stellantis
STLA
$20.8B
| $239K | ﹤0.01% |
+33,282
| New | +$247K |
|
|
MDRX
4378
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $239K | ﹤0.01% |
19,900
-16,400
| -45% | -$209K |
|
|
SSRI
4379
PUT
DELISTED
Silver Standard Resources
SSRI
| $239K | ﹤0.01% |
47,800
+6,000
| +14% | +$31.5K |
|
|
MHR
4380
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $239K | ﹤0.01% |
79,543
+3,423
| +4% | +$14.6K |
|
4381
PUT
Middleby
MIDD
$6.08B
| $238K | ﹤0.01% |
2,400
-2,100
| -47% | -$192K |
|
|
MCF
4382
PUT
DELISTED
Contango Oil & Gas Co.
MCF
| $238K | ﹤0.01% |
8,200
+300
| +4% | +$10.1K |
|
4383
PUT
Designer Brands
DBI
$333M
| $237K | ﹤0.01% |
6,400
-38,900
| -86% | -$1.27M |
|
4384
CALL
Sarepta Therapeutics
SRPT
$1.77B
| $237K | ﹤0.01% |
16,900
| – | – |
|
|
LCI
4385
DELISTED
Lannett Company, Inc.
LCI
| $237K | ﹤0.01% |
1,407
+924
| +191% | +$172K |
|
|
RATE
4386
DELISTED
Bankrate Inc
RATE
| $237K | ﹤0.01% |
19,719
+17,387
| +746% | +$197K |
|
4387
CALL
Bread Financial
BFH
$4.38B
| $236K | ﹤0.01% |
1,035
-44,324
| -98% | -$9.7M |
|
4388
PUT
HUB Group
HUBG
$2.92B
| $236K | ﹤0.01% |
12,400
-7,400
| -37% | -$138K |
|
4389
iShares Morningstar Growth ETF
ILCG
$3.27B
| $236K | ﹤0.01% |
10,440
| – | – |
|
|
JIVE
4390
PUT
DELISTED
Jive Software, Inc.
JIVE
| $236K | ﹤0.01% |
39,300
+3,100
| +9% | +$18.5K |
|
4391
CALL
Ameren
AEE
$30.1B
| $235K | ﹤0.01% |
5,100
-800
| -14% | -$34K |
|
|
NVO
4392
CALL
Novo Nordisk
NVO
$209B
| $235K | ﹤0.01% |
11,200
+1,200
| +12% | +$26.8K |
|
4393
Steven Madden
SHOO
$3.55B
| $235K | ﹤0.01% |
11,351
+6,902
| +155% | +$147K |
|
|
VSI
4394
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
| $235K | ﹤0.01% |
4,900
+2,100
| +75% | +$96.3K |
|
4395
PUT
BioCryst Pharmaceuticals
BCRX
$2.4B
| $234K | ﹤0.01% |
19,500
-100
| -0.5% | -$1.1K |
|
4396
ProShares UltraShort QQQ
QID
$247M
| $233K | ﹤0.01% |
75
-291
| -80% | -$977K |
|
4397
SouthState Bank Corp
SSB
$10.5B
| $233K | ﹤0.01% |
3,474
+3,181
| +1,086% | +$195K |
|
4398
CALL
Smith & Wesson
SWBI
$637M
| $233K | ﹤0.01% |
33,696
-5,334
| -14% | -$40K |
|
|
EJ
4399
CALL
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
| $233K | ﹤0.01% |
33,300
-42,521
| -56% | -$364K |
|
|
AMED
4400
CALL
DELISTED
Amedisys
AMED
| $232K | ﹤0.01% |
8,000
-3,700
| -32% | -$91.4K |
|
Similar funds
Barclays's Q4 2014 Portfolio in Review
As of Q4 2014, Barclays held 8,078 positions worth $104B, down 0.07% from $104B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays's Q4 2014 filing shows 340 new, 3,431 increased, 3,186 reduced and 767 closed positions. Its largest new stake was Vanguard Total International Bond ETF: 836,528 shares worth $44.3M. The largest sale was State Street SPDR S&P Retail ETF, an estimated $629M.
By sector, the portfolio is most concentrated in Healthcare at 5.7% of assets, up from 5.4% a quarter earlier, followed by Technology and Energy.
- Barclays's largest Q4 2014 buy was Vanguard Total International Bond ETF: 836,528 shares worth $44.3M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $2.44B increase.
- Barclays's biggest Q4 2014 reduction was State Street SPDR S&P Retail ETF, cutting an estimated $629M.
- Barclays fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $190M.
- Barclays's ten largest holdings make up 27% of its $104B portfolio in Q4 2014.
- Barclays opened 340 new positions and closed 767 in Q4 2014.
- Barclays's portfolio value fell 0.07% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q4 2014, filed 13 Feb 2015.